Antitumor effect of an injectable in-situ forming drug delivery system composed of a novel tissue adhesive containing doxorubicin hydrochloride

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 67, Issue 3, 2007, Pages 676-681

  Kakinoki, Sachiro ^a   Taguchi, Tetsushi ^a  

^a NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

Author keywords

Antitumor effect; Doxorubicin; Drug delivery system; Human serum albumin; Hydrogel; in situ forming; Injectable; N Hydroxysuccinimide; Tartaric acid; Tissue adhesive

Indexed keywords

DOXORUBICIN; HUMAN SERUM ALBUMIN; TARTARIC ACID DERIVATIVE; TISSUE ADHESIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; COLON CARCINOMA; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; TUMOR VOLUME;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BODY WEIGHT; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLONIC NEOPLASMS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; GELS; HUMANS; IMMUNOCOMPROMISED HOST; INJECTIONS, INTRAVENOUS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; TARTRATES; TISSUE ADHESIVES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 35348926358     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2007.03.020     Document Type: Article

References (38)

1. Panyam J., and Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55 (2003) 329-347
2. Bannon-Peppas L., and Blanchette J.O. Nanoparticle and targeted system for cancer therapy. Adv. Drug Deliv. Rev. 56 (2004) 1649-1659
3. Barraud L., Merle P., Soma E., Lefrancois L., Guerret S., Chevallier M., Dubernet C., Couvreur P., Trépo C., and Vitvitski L. Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J. Hepatol. 42 (2005) 736-743
4. Kakinoki S., Yasuda C., Kaetsu I., Uchida K., Yukutake K., Nakayama M., Fujiie S., Kuroda D., Kato M., and Ohyanagi H. Preparation of poly-lactic acid microsphere containing the angiogenesis inhibitor TNP-470 with medium-chain triglyceride and the in vitro evaluation of release profiles. Eur. J. Pharm. Biopharm. 55 (2003) 155-160
5. Freiberg S., and Zhu X.X. Polymer microsphere for controlled drug release. Int. J. Pharm. 282 (2004) 1-18
6. Nishiyama N., Bae Y., Miyata K., Fukushima S., and Kataoka K. Smart polymeric micelles for gene and drug delivery. Drug Discov. Today 2 (2005) 21-26
7. Rapoport N., Pitt W.G., Sun H., and nelson J.L. Drug delivery in polymeric micelles: from in vitro to in vivo. J. Control. Release 91 (2003) 85-95
8. Mrubỳ M., Koňák C., and Ulbrich K. Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J. Control. Release 103 (2005) 137-148
9. Goyal P., Goyal K., Kumar S.G., Singh A., Katare O.P., and Mishra D.N. Liposomal drug delivery systems - clinical applications. Acta Pharm. 55 (2005) 1-25
10. Kaneda Y. Virosomes: evoluation of the liposome as a targeted drug delivery system. Adv. Drug Deliv. Rev. 43 (2000) 197-205
11. Saul J.M., Annapragada A., Natarajan J.V., and Bellamkonda R.V. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J. Control. Release 92 (2003) 49-67
12. Abraham S.A., Waterhouse D.N., Mayer L.D., Cullis P.R., madden T.D., and Bally M.B. The liposomal formulation of doxorubicin. Methods Enzymol. 391 (2005) 71-97
13. He H., Cao X., and Lee L.J. Design of a novel hydrogel-based intelligent system for controlled drug release. J. Control. Release 95 (2004) 391-402
14. Hoffman A.S. Hydrogels for biomedical applications. Adv. Drug Deliv. Rev. 54 (2002) 3-12
15. Packhaeuser C.B., Schnieders J., Oster C.G., and Kissel T. In situ forming parenteral drug delivery systems: an overview. Eur. J. Pharm. Biopharm. 58 (2004) 445-455
16. Ibusuki S., Fuji Y., Iwamoto Y., and Matsuda T. Tissue-engineered cartilage using an injectable and in situ gelable thermoresponsive gelatin: fabrication and in vitro performance. Tissue Eng. 9 (2003) 371-384
17. Malmsten M., and Lindman B. Self-assembly in aqueous block copolymer solutions. Macromolecules 25 (1992) 5440-5445
18. Gariépy E.R., and Leroux J.C. In situ-forming hydrogels - review of temperature-sensitive systems. Eur. J. Pharm. Biopharm. 58 (2004) 409-426
19. Draget K.I., Bræk G.S., and Smidsrød O. Alginate based new materials. Int. J. Biol. Macromol. 21 (1997) 47-55
20. Lee K.Y., and Mooney D.J. Hydrogels for tissue engineering. Chem. Rev. 101 (2001) 1869-1879
21. Sultzbaugh K.J., and Speaker T.J. A method to attach lectins to the surface of spermine alginate microcapsules based on the avidin biotin interaction. J. Microencapsul. 13 (1996) 363-376
22. Rowley J.A., Madlambayan G., and Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20 (1990) 45-53
23. Taguchi T., Saito H., Uchida Y., Sakane M., Kobayashi H., Kataoka K., and Tanaka J. Bonding of soft tissues using a novel tissue adhesive consisting of a citric acid derivative and collagen. Mater. Sci. Eng. C. - Biomimetic Supramol. Syst. 24 (2004) 775-780
24. Saito H., Taguchi T., Kobayashi H., Kataoka K., Tanaka J., Murabayashi S., and Mitamura Y. Physicochemical properties of gelatin gels prepared using citric acid derivative. Mater. Sci. Eng. C. - Biomimetic Supramol. Syst. 24 (2004) 781-785
25. Aoki H., Taguchi T., Saito H., Kobayashi H., Kataoka K., and Tanaka J. Rheological evaluation of gelatin gels prepared with a citric acid derivative as a novel cross-linker. Mater. Sci. Eng. C. - Biomimetic Supramol. Syst. 24 (2004) 787-790
26. Taguchi T., Saito H., Iwasashi M., Sakane M., Kakinoki S., Ochiai N., and Tateishi T. Development of biocompatible glue for minimum invasive therapy. Key Eng. Mater. 330-332 (2007) 1339-1342
27. Taguchi T., Saito H., Iwasashi M., Sakane M., Kakinoki S., and Tanaka J. J. Nanosci. Nanotechnol. 7 (2007) 742-747
28. In: Quinn J.V. (Ed). Tissue Adhesives in Clinical Medicine (2005), BC Decker Inc, Ontario
29. Singer A.J., and Thode Jr. H.C. A review of the literature on octylcyanoacrylate tissue adhesive. Am. J. Surg. 187 (2004) 238-248
30. Radosevich M., Goubran H.A., and Burnouf T. Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. Vox Sang. 72 (1997) 133-143
31. Braunwald N.S., Gay W., and Tatooles C.J. Evaluation of crosslinked gelatin as a tissue adhesive and hemostatic agent: an experimental study. Surgery 59 (1966) 1024-1030
32. Yu B.G., Kwon I.C., Kim Y.H., Han D.K., Park K.D., Han K., and Jeong S.Y. Development of a local antibiotic delivery system using fibrin glue. J. Control. Release 39 (1996) 65-70
33. Kitazawa H., Sato H., Adachi I., Masuko Y., and Horikoshi I. Microdialysis assessment of fibrin glue containing sodium alginate for local delivery of doxorubicin in tumor-bearing rats. Biol. Pharm. Bull. 20 (1997) 278-281
34. Yoshida H., Yamaoka Y., Shinoyama M., and Kamiya A. Novel drug delivery system using autologous fibrin glue - release properties of anti-cancer drugs. Biol. Pharm. Bull. 23 (2000) 371-374
35. S. Kakinoki, T. Taguchi, J. Tanaka, T. Tateishi, The injectable in situ forming drug delivery system for cancer chemotherapy using the novel tissue adhesive: characterization and in vitro evaluation, Eur. J. Pharm. Biopharm. (in press).
36. Ovejera A.A., and Houchens D.P. Human tumor xenografts in athymic nude mice as a preclinical screen for anticancer agents. Semin. Oncol. 8 (1981) 386-393
37. Iwata H., Matsuda S., Mitsuhashi K., Itoh E., and Ikada Y. A novel surgical glue composed of gelatin and N-hydroxysuccinimide activated poly(l-glutamic acid) Part 1. Synthesis of activated poly(l-glutamic acid) and its gelation with gelatin. Biomaterials 19 (1998) 1869-1876
38. Allen J.S., and Panfili J. Ames Salmonella/mammalian-microsome testing of peptides and peptide synthesis reagents. Mutat. Res. 170 (1986) 23-29